510(k) Report

510(k) · Cleared

Cleared

EndoTool IV Cloud 1.0

K260910510(k) TraditionalCleared May 1, 202643-day reviewClass II21 CFR 868.1890

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Glooko, Inc. · NDC Calculator, Drug Dose

Cleared on May 1, 2026 as substantially equivalent to K241088 (Monarch Medical Technologies, 2024) after a 43-day review. Its family tree reaches back 13 generations to 1994. 1 of the 40 devices in its family, counting itself, has a Class I recall.

Decided
May 1, 2026
Review
43 days
Class
Class II
Product code
NDC
Recalls
None
Predicates
1

Its longest line of descent runs back 13 generations to K941811 (1994). 39 ancestors in all, the oldest K822695 (1982). No later device cites it as a predicate yet. 1 of the 40 devices in this family, counting this one, has a Class I recall.

  1. Root · 13 generations backK941811 HP M1175A, M1176A, Component Monitoring SystemHewlett-Packard Co. · 1994
  2. 9 generations between
  3. 3 generations backK200443 EndoTool IV 1.10Monarch Medical Technologies, LLC · 2020
  4. 2 generations backK201619 EndoTool IV SystemMonarch Medical Technologies, LLC · 2020
  5. 1 generation backK241088 EndoTool IV (3.1)Monarch Medical Technologies · 2024
  6. This deviceK260910 EndoTool IV Cloud 1.0Glooko, Inc. · 2026
Show all 13 generations
  1. Root · 13 generations backK941811 HP M1175A, M1176A, Component Monitoring SystemHewlett-Packard Co. · 1994
  2. 12 generations backK960934 HP M1205A Omnicare Component Monitor System Model 24Hewlett-Packard Co. · 1996
  3. 11 generations backK981376 Hewlett-Packard M1205A Viridia 24 CTHewlett-Packard Co. · 1999
  4. 10 generations backK990125 HP Viridia Component Monitoring System, Model Rev. KHewlett-Packard GmbH · 1999
  5. 9 generations backK992636 HP Carevue 9000 Clinical Information System, Model M2331AHewlett-Packard Co. · 1999 · Recalled
  6. 8 generations backK023674 Philips Drug Calculator SoftwarePhilips Medical Systems · 2002
  7. 7 generations backK061110 Glucommander PlusCollaborativemed, LLC · 2006
  8. 6 generations backK101344 G+ SystemGlytec, LLC (Formally Known AS Glucotec, Inc.) · 2010
  9. 5 generations backK113853 G+ SystemGlytec, LLC · 2012
  10. 4 generations backK132547 Endo Tool Glucose Management System (Egms)Monarch Medical Technologies · 2014 · Recalled
  11. 3 generations backK200443 EndoTool IV 1.10Monarch Medical Technologies, LLC · 2020
  12. 2 generations backK201619 EndoTool IV SystemMonarch Medical Technologies, LLC · 2020
  13. 1 generation backK241088 EndoTool IV (3.1)Monarch Medical Technologies · 2024
  14. This deviceK260910 EndoTool IV Cloud 1.0Glooko, Inc. · 2026

Class I recalls in this family

View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−13K941811HP M1175A, M1176A, Component Monitoring SystemHewlett-Packard Co.1994—
−12K960934HP M1205A Omnicare Component Monitor System Model 24Hewlett-Packard Co.1996—
−11K981376Hewlett-Packard M1205A Viridia 24 CTHewlett-Packard Co.1999—
−10K990125HP Viridia Component Monitoring System, Model Rev. KHewlett-Packard GmbH1999—
−9K992636HP Carevue 9000 Clinical Information System, Model M2331AHewlett-Packard Co.19998
−8K023674Philips Drug Calculator SoftwarePhilips Medical Systems2002—
−7K061110Glucommander PlusCollaborativemed, LLC2006—
−6K101344G+ SystemGlytec, LLC (Formally Known AS Glucotec, Inc.)2010—
−5K113853G+ SystemGlytec, LLC2012—
−4K132547Endo Tool Glucose Management System (Egms)Monarch Medical Technologies20141
−3K200443EndoTool IV 1.10Monarch Medical Technologies, LLC2020—
−2K201619EndoTool IV SystemMonarch Medical Technologies, LLC2020—
−1K241088EndoTool IV (3.1)Monarch Medical Technologies2024—
0 (this device)K260910EndoTool IV Cloud 1.0Glooko, Inc.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198210
199230
199310
199410
199510
199610
199720
199810
199940
200010
200120
200220
200431
200520
200610
FIG. 1 — Lineage of K260910, 1994–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NDC device

  1. #1 K242775 InPen System App (MMT-8060 (iOS), MMT-8061…score 18.0 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K241088EndoTool IV (3.1)
Summary page 5
…ission Number: K260910 V. PREDICATE DEVICE Predicate Manufacturer: Monarch Medical Technologies Predicate Trade Name: EndoTool IV 3.1 System Predicate 510(k): K241088 No reference devices were used in this submission. VI. DEVICE DESCRIPTION EndoTool Cloud 1.0 is a software system for glucose m…
Monarch Medical Technologies2024—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K042873Animas Model IR1250 Insulin Infusion PumpAnimas Corp. · 2004 · 8 generations back · ◆ in the 2004 ancestors bar of FIG. 11 Class I recall

What does this lineage say?

  • The line of descent spans 32 years and passes through 9 companies; a new generation was cleared every 2.1 years on median.
  • 7 of the 39 ancestors have a recall of any class; 1 has a Class I recall.

How does its category compare?

All NDC devices

NDC Calculator, Drug Dose: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · NDC

2in 2025

2007: 12008: 22010: 12012: 22014: 32015: 32016: 22017: 82018: 32019: 12020: 52021: 32023: 32024: 32025: 22026 (partial year): 4
2007high 8 (2017) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NDC

60in 2024

2014: 118 days median2015: 199 days median2017: 189 days median2018: 220 days median2020: 53 days median2021: 269 days median2023: 126 days median2024: 60 days median2026 (partial year): 90 days median
2007high 269 (2021) · low 53 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NDC

1in 2025

2016: 12017: 22018: 12019: 12022: 12025: 12026 (partial year): 2
2007high 2 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NDC

299in 2025

2008: 72009: 42010: 182011: 112012: 22013: 12014: 12015: 12016: 182017: 252018: 212019: 182020: 102021: 112022: 3472023: 4632024: 1682025: 299
2007high 463 (2023) · low 0 (2007)2025

MAUDE reports naming product code NDC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—07
20090—04
20101—018
20110—011
20122—02
20130—01
2014311801
2015319901
20162—118
20178189225
20183220121
20191—118
2020553010
20213269011
20220—1347
202331260463
20243600168
20252—1299
20264902—

What is it indicated for?

EndoTool Cloud is intended for use by trained healthcare professionals in inpatient care settings to assist in the management of blood glucose levels in adult and pediatric patients aged two years and older who weigh at least 12 kg. The software is intended to recommend patient-specific intravenous insulin dosing, carbohydrate dosing for recovery of or supplementation, and subcutaneous insulin dosing for the transition from intravenous therapy and for…

Read the full statement (172 words)

EndoTool Cloud is intended for use by trained healthcare professionals in inpatient care settings to assist in the management of blood glucose levels in adult and pediatric patients aged two years and older who weigh at least 12 kg. The software is intended to recommend patient-specific intravenous insulin dosing, carbohydrate dosing for recovery of or supplementation, and subcutaneous insulin dosing for the transition from intravenous therapy and for ongoing management of hyperglycemia.

EndoTool Cloud generates dosing recommendations based on the prescribing healthcare provider’s orders for target glucose range, dosing mode and patient-specific clinical characteristics. The software is intended to assist healthcare professionals in adjusting and maintaining a patient’s glucose level within a configurable, clinician-determined target range.

The EndoTool Cloud logic is not a substitute for clinical judgment but is intended as a decision support tool for trained healthcare professionals. Final dose decisions must be made by the healthcare professional after consideration of the patient’s overall clinical status. No medical decision should be made solely based on the recommendations provided by this software.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K260910: EndoTool IV Cloud 1.0.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K260910

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026